Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.
about
Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cellsTryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolitesGSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactionsEstablishment and Dysfunction of the Blood-Brain Barrier.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's diseaseTargeting cerebrovascular impairments in Huntington's disease: a novel treatment perspective.Vectorized nanodelivery systems for ischemic stroke: a concept and a need.Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease.Is Huntington's disease a tauopathy?Pyruvate blocks blood-brain barrier disruption, lymphocyte infiltration and immune response in excitotoxic brain injury.Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) miceRegulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone.Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease.Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease.Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease.Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease.Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.Disrupted vasculature and blood-brain barrier in Huntington disease.Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits.Glycosylation of dentin matrix protein 1 is a novel key element for astrocyte maturation and BBB integrity.The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications.Mutant huntingtin protein expression and blood-spinal cord barrier dysfunction in huntington disease.In Vitro Microfluidic Models for Neurodegenerative Disorders.Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis.Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component.Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality.MRI techniques to measure arterial and venous cerebral blood volume.Salivary levels of total huntingtin are elevated in Huntington's disease patients.Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease.Targeting pericytes for therapeutic approaches to neurological disorders
P2860
Q28822276-CC85C2C5-AEF9-4910-8F60-464FD4999F2FQ28834131-F04749AD-45C1-4A17-8A40-8C979EA408AAQ36002017-118768EC-39B8-482A-99E7-7157430167FDQ36306827-A486AB1E-2D68-49D2-8122-61AA79EA4F29Q36767796-9338C2D5-7103-48AC-8B4E-3C1AB10BE3C0Q38620375-D94F8B01-0E57-411A-9C12-2B38D1226444Q38731765-D7B7CBAC-6607-4489-9852-BBF9FC9B1405Q38766477-8D118842-EC9F-49B9-83CC-DB6B6DF6E8D3Q38771048-956C612B-3B96-4A4C-ACD9-DF2DAB3BFA2DQ38950972-65595D01-449F-40C3-8436-3588DEF4319EQ39233225-D4518A38-F96F-4367-AA78-97115A03D844Q41842714-8B22BCAA-9A2D-47F4-B3AF-D45D04FF2CFCQ42135650-475FB9B7-C10B-40B3-BB83-3A775E828390Q45293191-4C10ECF4-5C31-4A4C-B4E2-2BE2C2BA4583Q45295362-DA7A428D-FEE7-4655-9604-F1182B5F4EF8Q45299733-18F4356B-1A6C-414C-8310-F33D9E79A84AQ45305588-3B2313B1-6817-4C56-941D-61E15484B99DQ45305883-82B204B3-644A-4AD3-A658-8C7D8F03D95FQ45306205-97F14F3B-BCB9-4EB7-BEC2-5C7A05116A6CQ45611249-5F3430C4-9D0C-4BA8-B767-3D6107CA143CQ46403676-24C22564-A6AD-42D1-8483-D968D4FF17CAQ47102449-279D42F6-6E18-4716-8A02-45D836D485CBQ47368283-ABF7CC95-7600-4252-A65E-F192EFAEB26BQ47704356-ED8EC065-25AF-42B6-A63F-024D17089DD6Q47707801-3A80E262-DE40-4E50-BEF2-381838509E38Q47830673-C8EA8ACE-82D2-4DB0-9091-9FF73BA99970Q47998495-183CC01B-68CF-4CFA-9C00-9AA349BB30D5Q48292903-94D07569-F266-4851-BF6F-55B0810361B5Q49846143-2142BC18-0468-438E-B342-74F685208C74Q54965947-168518C7-39A3-4555-891C-CEF9BF5D9124Q55514851-C22C5276-D4F7-47EF-80BC-CF72A0A73D3DQ56962810-0D0B3DA8-4873-4B6C-B815-1A90D3EB8FDF
P2860
Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@en
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@nl
type
label
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@en
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@nl
prefLabel
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@en
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Cerebrovascular and blood-brai ...... tions for its pathophysiology.
@en
P2093
Francesca Cicchetti
Janelle Drouin-Ouellet
Marie Lagacé
Martine Saint-Pierre
Penny A Gowland
Richard J Dury
Sarah L Mason
Wael Alata
P2860
P304
P356
10.1002/ANA.24406
P50
P577
2015-04-09T00:00:00Z